Global Biosimilar Monoclonal Antibodies Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2023

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jun-2018   |    Format :PDF   |    Number of Pages : 111
This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Biosimilar Monoclonal Antibodies market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
    ProMab Biotechnologies
    Allergan plc
    Abbott
    BioXpress Therapeutics
    Bayer
    Bio Farma
    Merck
    Therapeutics
    Biocon
    Boehringer Ingelheim
    Celltrion Inc.
    Coherus BioSciences Inc.
    Zydus-Cadila
    Genor BioPharma
    Intas Pharmaceuticals
    Novartis
    Pfizer
    Reliance Life Sciences

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    India
    Southeast Asia
    Other regions (Central & South America, Middle East & Africa)

The regional scope of the study is as follows:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Infliximab
    Rituximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab

By Application, the market can be split into
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

The study objectives of this report are:
    To analyze and study the global Biosimilar Monoclonal Antibodies capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Biosimilar Monoclonal Antibodies manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biosimilar Monoclonal Antibodies Manufacturers
Biosimilar Monoclonal Antibodies Distributors/Traders/Wholesalers
Biosimilar Monoclonal Antibodies Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biosimilar Monoclonal Antibodies market, by end-use.
Detailed analysis and profiles of additional market players.

Global Biosimilar Monoclonal Antibodies Market Professional Survey Report 2018
1 Industry Overview of Biosimilar Monoclonal Antibodies
    1.1 Definition and Specifications of Biosimilar Monoclonal Antibodies
        1.1.1 Definition of Biosimilar Monoclonal Antibodies
        1.1.2 Specifications of Biosimilar Monoclonal Antibodies
    1.2 Classification of Biosimilar Monoclonal Antibodies
        1.2.1 Infliximab
        1.2.2 Rituximab
        1.2.3 Abciximab
        1.2.4 Trastuzumab
        1.2.5 Adalimumab
        1.2.6 Bevacizumab
    1.3 Applications of Biosimilar Monoclonal Antibodies
        1.3.1 Oncology
        1.3.2 Chronic and Autoimmune Diseases
        1.3.3 Growth Hormone Deficiency
        1.3.4 Infectious Diseases
        1.3.5 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
    2.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    2.4 Industry Chain Structure of Biosimilar Monoclonal Antibodies

3 Technical Data and Manufacturing Plants Analysis of Biosimilar Monoclonal Antibodies
    3.1 Capacity and Commercial Production Date of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    3.3 R&D Status and Technology Source of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    3.4 Raw Materials Sources Analysis of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017

4 Global Biosimilar Monoclonal Antibodies Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-2018E Global Biosimilar Monoclonal Antibodies Capacity and Growth Rate Analysis
        4.2.2 2017 Biosimilar Monoclonal Antibodies Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-2018E Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Analysis
        4.3.2 2017 Biosimilar Monoclonal Antibodies Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-2018E Global Biosimilar Monoclonal Antibodies Sales Price
        4.4.2 2017 Biosimilar Monoclonal Antibodies Sales Price Analysis (Company Segment)

5 Biosimilar Monoclonal Antibodies Regional Market Analysis
    5.1 North America Biosimilar Monoclonal Antibodies Market Analysis
        5.1.1 North America Biosimilar Monoclonal Antibodies Market Overview
        5.1.2 North America 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.1.4 North America 2017 Biosimilar Monoclonal Antibodies Market Share Analysis
    5.2 Europe Biosimilar Monoclonal Antibodies Market Analysis
        5.2.1 Europe Biosimilar Monoclonal Antibodies Market Overview
        5.2.2 Europe 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.2.4 Europe 2017 Biosimilar Monoclonal Antibodies Market Share Analysis
    5.3 China Biosimilar Monoclonal Antibodies Market Analysis
        5.3.1 China Biosimilar Monoclonal Antibodies Market Overview
        5.3.2 China 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.3.4 China 2017 Biosimilar Monoclonal Antibodies Market Share Analysis
    5.4 Japan Biosimilar Monoclonal Antibodies Market Analysis
        5.4.1 Japan Biosimilar Monoclonal Antibodies Market Overview
        5.4.2 Japan 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.4.4 Japan 2017 Biosimilar Monoclonal Antibodies Market Share Analysis
    5.5 Southeast Asia Biosimilar Monoclonal Antibodies Market Analysis
        5.5.1 Southeast Asia Biosimilar Monoclonal Antibodies Market Overview
        5.5.2 Southeast Asia 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.5.4 Southeast Asia 2017 Biosimilar Monoclonal Antibodies Market Share Analysis
    5.6 India Biosimilar Monoclonal Antibodies Market Analysis
        5.6.1 India Biosimilar Monoclonal Antibodies Market Overview
        5.6.2 India 2013-2018E Biosimilar Monoclonal Antibodies Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-2018E Biosimilar Monoclonal Antibodies Sales Price Analysis
        5.6.4 India 2017 Biosimilar Monoclonal Antibodies Market Share Analysis

6 Global 2013-2018E Biosimilar Monoclonal Antibodies Segment Market Analysis (by Type)
    6.1 Global 2013-2018E Biosimilar Monoclonal Antibodies Sales by Type
    6.2 Different Types of Biosimilar Monoclonal Antibodies Product Interview Price Analysis
    6.3 Different Types of Biosimilar Monoclonal Antibodies Product Driving Factors Analysis
        6.3.1 Infliximab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        6.3.2 Rituximab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        6.3.3 Abciximab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        6.3.4 Trastuzumab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        6.3.5 Adalimumab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        6.3.6 Bevacizumab of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis

7 Global 2013-2018E Biosimilar Monoclonal Antibodies Segment Market Analysis (by Application)
    7.1 Global 2013-2018E Biosimilar Monoclonal Antibodies Consumption by Application
    7.2 Different Application of Biosimilar Monoclonal Antibodies Product Interview Price Analysis
    7.3 Different Application of Biosimilar Monoclonal Antibodies Product Driving Factors Analysis
        7.3.1 Oncology of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        7.3.2 Chronic and Autoimmune Diseases of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        7.3.3 Growth Hormone Deficiency of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        7.3.4 Infectious Diseases of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis
        7.3.5 Others of Biosimilar Monoclonal Antibodies Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Biosimilar Monoclonal Antibodies
    8.1 ProMab Biotechnologies
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 ProMab Biotechnologies 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 ProMab Biotechnologies 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.2 Allergan plc
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Allergan plc 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Allergan plc 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.3 Abbott
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Abbott 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Abbott 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.4 BioXpress Therapeutics
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 BioXpress Therapeutics 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 BioXpress Therapeutics 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.5 Bayer
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Bayer 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Bayer 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.6 Bio Farma
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Bio Farma 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bio Farma 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.7 Merck
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Merck 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Merck 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.8 Therapeutics
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Therapeutics 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Therapeutics 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.9 Biocon
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Biocon 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Biocon 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.10 Boehringer Ingelheim
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Boehringer Ingelheim 2017 Biosimilar Monoclonal Antibodies Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Boehringer Ingelheim 2017 Biosimilar Monoclonal Antibodies Business Region Distribution Analysis
    8.11 Celltrion Inc.
    8.12 Coherus BioSciences Inc.
    8.13 Zydus-Cadila
    8.14 Genor BioPharma
    8.15 Intas Pharmaceuticals
    8.16 Novartis
    8.17 Pfizer
    8.18 Reliance Life Sciences

9 Development Trend of Analysis of Biosimilar Monoclonal Antibodies Market
    9.1 Global Biosimilar Monoclonal Antibodies Market Trend Analysis
        9.1.1 Global 2018-2025 Biosimilar Monoclonal Antibodies Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Biosimilar Monoclonal Antibodies Sales Price Forecast
    9.2 Biosimilar Monoclonal Antibodies Regional Market Trend
        9.2.1 North America 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
        9.2.2 Europe 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
        9.2.3 China 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
        9.2.4 Japan 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
        9.2.5 Southeast Asia 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
        9.2.6 India 2018-2025 Biosimilar Monoclonal Antibodies Consumption Forecast
    9.3 Biosimilar Monoclonal Antibodies Market Trend (Product Type)
    9.4 Biosimilar Monoclonal Antibodies Market Trend (Application)

10 Biosimilar Monoclonal Antibodies Marketing Type Analysis
    10.1 Biosimilar Monoclonal Antibodies Regional Marketing Type Analysis
    10.2 Biosimilar Monoclonal Antibodies International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Biosimilar Monoclonal Antibodies by Region
    10.4 Biosimilar Monoclonal Antibodies Supply Chain Analysis

11 Consumers Analysis of Biosimilar Monoclonal Antibodies
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Biosimilar Monoclonal Antibodies Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of Biosimilar Monoclonal Antibodies
    Table Product Specifications of Biosimilar Monoclonal Antibodies
    Table Classification of Biosimilar Monoclonal Antibodies
    Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Type in 2017
    Figure Infliximab Picture
    Table Major Manufacturers of Infliximab
    Figure Rituximab Picture
    Table Major Manufacturers of Rituximab
    Figure Abciximab Picture
    Table Major Manufacturers of Abciximab
    Figure Trastuzumab Picture
    Table Major Manufacturers of Trastuzumab
    Figure Adalimumab Picture
    Table Major Manufacturers of Adalimumab
    Figure Bevacizumab Picture
    Table Major Manufacturers of Bevacizumab
    Table Applications of Biosimilar Monoclonal Antibodies
    Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Application in 2017
    Figure Oncology Examples
    Table Major Consumers in Oncology
    Figure Chronic and Autoimmune Diseases Examples
    Table Major Consumers in Chronic and Autoimmune Diseases
    Figure Growth Hormone Deficiency Examples
    Table Major Consumers in Growth Hormone Deficiency
    Figure Infectious Diseases Examples
    Table Major Consumers in Infectious Diseases
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Biosimilar Monoclonal Antibodies by Regions
    Figure North America Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Figure China Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Figure Japan Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Figure India Biosimilar Monoclonal Antibodies Market Size (Million USD) (2013-2025)
    Table Biosimilar Monoclonal Antibodies Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies in 2017
    Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure Industry Chain Structure of Biosimilar Monoclonal Antibodies
    Table Capacity and Commercial Production Date of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table Manufacturing Plants Distribution of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table R&D Status and Technology Source of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table Raw Materials Sources Analysis of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2013-2018E
    Figure Global 2013-2018E Biosimilar Monoclonal Antibodies Market Size (Volume) and Growth Rate
    Figure Global 2013-2018E Biosimilar Monoclonal Antibodies Market Size (Value) and Growth Rate
    Table 2013-2018E Global Biosimilar Monoclonal Antibodies Capacity and Growth Rate
    Table 2017 Global Biosimilar Monoclonal Antibodies Capacity (K Units) List (Company Segment)
    Table 2013-2018E Global Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate
    Table 2017 Global Biosimilar Monoclonal Antibodies Sales (K Units) List (Company Segment)
    Table 2013-2018E Global Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Table 2017 Global Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E 
    Figure North America 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Figure North America 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E 
    Figure Europe 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) 
    Figure Europe 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E
    Figure China 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Figure China 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E
    Figure Japan 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Figure Japan 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E
    Figure Southeast Asia 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Figure Southeast Asia 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Biosimilar Monoclonal Antibodies 2013-2018E
    Figure India 2013-2018E Biosimilar Monoclonal Antibodies Sales Price (USD/Unit)
    Figure India 2017 Biosimilar Monoclonal Antibodies Sales Market Share
    Table Global 2013-2018E Biosimilar Monoclonal Antibodies Sales (K Units) by Type
    Table Different Types Biosimilar Monoclonal Antibodies Product Interview Price
    Table Global 2013-2018E Biosimilar Monoclonal Antibodies Sales (K Units) by Application
    Table Different Application Biosimilar Monoclonal Antibodies Product Interview Price
    Table ProMab Biotechnologies Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Allergan plc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Allergan plc Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Allergan plc Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Abbott Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Abbott Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Abbott Biosimilar Monoclonal Antibodies Business Region Distribution
    Table BioXpress Therapeutics Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Bayer Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Bayer Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Bayer Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Bio Farma Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Bio Farma Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Bio Farma Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Merck Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Merck Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Merck Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Therapeutics Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Therapeutics Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Therapeutics Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Biocon Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Biocon Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Biocon Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Boehringer Ingelheim Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Business Region Distribution
    Table Celltrion Inc. Information List
    Table Coherus BioSciences Inc. Information List
    Table Zydus-Cadila Information List
    Table Genor BioPharma Information List
    Table Intas Pharmaceuticals Information List
    Table Novartis Information List
    Table Pfizer Information List
    Table Reliance Life Sciences Information List
    Figure Global 2018-2025 Biosimilar Monoclonal Antibodies Market Size (K Units) and Growth Rate Forecast
    Figure Global 2018-2025 Biosimilar Monoclonal Antibodies Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Forecast
    Figure North America 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2018-2025 Biosimilar Monoclonal Antibodies Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Biosimilar Monoclonal Antibodies by Type 2018-2025
    Table Global Consumption Volume (K Units) of Biosimilar Monoclonal Antibodies by Application 2018-2025
    Table Traders or Distributors with Contact Information of Biosimilar Monoclonal Antibodies by Region



Latest News

15-Jan-2019 | Medical Care

Health Insurance Market In China Witnessing A Huge Boom Over High Premium Plan Demand

Medicare has outpaced life insurance policies in China as the fastest-growing category of the industry as wealthy consumers try to fill the insufficient public coverage. The emergence of health ins ...

14-Jan-2019 | Electrical & Electronic Device

Growing Collaboration For Futuristic Product Development To Lead Pharmaceutical Market Growth

C-LEcta, a global technology leader in enzyme technology and bioprocess development for controlled markets such as the food and pharmaceutical industry, has inked two duration cooperation agreement ...

03-Dec-2018 | Technology

Don’t await a 5G iPhone on or before 2020

Apple’s timeline for adopting the next generation of cellular connectivity, 5G, by suggesting the first compatible iPhone won’t come before 2020. Earlier rumors and reports pointed to t ...

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...